Search

everythinglearnresearchcommunity

for

Search:↓

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Dystonia may be part of PAS-4 and linked to immune issues.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

GLP-1 receptor agonists can cause skin reactions, facial fat loss, and hair loss, but may help with wound healing and skin conditions.

GLP-1 receptor agonists may help or harm hair health, needing more research.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

Diphencyprone increases Bcl-2 protein in patients with hair regrowth from alopecia areata.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Dutasteride may reduce insulin sensitivity and increase body fat.

GLP-1 agonists may increase the risk of hair loss.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

Tirzepatide may improve hair loss by reducing insulin resistance.

A new compound, HTPI, promotes hair growth by protecting cells from damage and regulating energy use.

Finasteride may worsen blood sugar control in diabetic patients.

Different types of PPARγ are found in varying amounts in human skin and its parts, which could affect how skin treatments work.

Lifestyle changes are more effective than metformin for reducing type 2 diabetes risk.

Janus kinase inhibitors may help treat lichen planopilaris.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Finasteride may help reduce impulsivity caused by pramipexole.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.